WebMannKind Corporation Reports 2024 Third Quarter Financial Results. Seeking Alpha 136d. MannKind GAAP EPS of -$0.06 beats by $0.02, revenue of $32.83M beats by $7.83M. … Web11. apr 2024. · What is MannKind's consensus rating and price target? According to the issued ratings of 1 analysts in the last year, the consensus rating for MannKind stock is Buy based on the current 1 buy rating for MNKD. The average twelve-month price prediction for MannKind is $6.50 with a high price target of $7.00 and a low price target of $6.00.
MNKD Price Target 2024 MannKind Analyst Ratings - MarketBeat
Web7 Penny Sleeper Stocks to Buy Before Wall Street Wakes Up. Sep 24, 2024. Even though MannKind Corporation's (NASDAQ:MNKD) stock is down 14% this week, insiders who … Web09. avg 2024. · MannKind Corporation to Hold 2024 Fourth Quarter and Full Year Financial Results Conference Call on February 23, 2024 • GlobeNewswire Inc. • 02/16/2024 … 鬼姑との戦い 63
How Many MannKind Corporation (NASDAQ:MNKD) Shares Do …
WebMannKind Corporation Common Stock ( MNKD) - Nasdaq. Key Data ; Share Volume, 395,359 ; Average Volume, 3,371,482 ; Previous Close, $4.75 ; 52 Week High/Low, $5.7299/$2.61. MannKind Corp MNKD Stock Quote - NASDAQ - Morningstar. See the latest MannKind Corp stock price (NASDAQ: MNKD ), related news, valuation, … Web01. mar 2024. · WESTLAKE VILLAGE, Calif., March 01, 2024 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) today announced that it intends to offer, … Web17. maj 2024. · The once-daily insulin delivery device strengthens MannKind’s commitment to offering innovative mealtime diabetes solutions; DANBURY, Conn. and WESTLAKE VILLAGE, Calif., May 17, 2024 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of therapeutic … tar格式压缩包